F. , C. Ld, K. , A. Boulogne-), G. Galeazzi et al., Conflicts of interest OL and MW: member of speaker's bureau Merck SB: member of speaker's bureau Gilead none Ethical standards The research described herein was carried out in compliance with French law and the Declaration of Helsinki (as adopted in 2000), and was approved by the Institut Pasteur institutional review board (IRB #2009-34) Approval of the ''Commission Nationale de l'Informatique et des Libertés'' was obtained, ensuring that the patients' data were kept anonymous according to French regulations. Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. Appendix The following investigators participated in the YEASTS program of the French Mycosis Study Group: collection of data in each participating center: C. Bouges-Michel (hôpital Avicenne, Bobigny), I. Poilane (hôpital Jean Verdier, program was supported in part by Institut de Veille Sanitaire and Institut Pasteur. The funders had no role in study design, data collection

S. Mariani, Bonacorsi (hôpital Robert Debré) Technical analysis of the isolates at the National Reference Center for Invasive Mycoses and Antifungals: Marie Desnos- Ollivier

R. 1. Marchetti, O. Bille, J. Fluckiger, U. Eggimann, P. Ruef et al., Epidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991???2000, Clinical Infectious Diseases, vol.38, issue.3, pp.311-320, 1991.
DOI : 10.1086/380637

A. Marra, L. Camargo, A. Pignatari, T. Sukiennik, P. Behar et al., Nosocomial Bloodstream Infections in Brazilian Hospitals: Analysis of 2,563 Cases from a Prospective Nationwide Surveillance Study, Journal of Clinical Microbiology, vol.49, issue.5, pp.1866-1871, 2011.
DOI : 10.1128/JCM.00376-11

H. Wisplinghoff, T. Bischoff, S. Tallent, H. Seifert, R. Wenzel et al., Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study, Clinical Infectious Diseases, vol.39, issue.3, pp.309-317, 2004.
DOI : 10.1086/421946

T. Zaoutis, J. Argon, J. Chu, J. Berlin, T. Walsh et al., The Epidemiology and Attributable Outcomes of Candidemia in Adults and Children Hospitalized in the United States: A Propensity Analysis, Clinical Infectious Diseases, vol.41, issue.9, pp.1232-1239, 2005.
DOI : 10.1086/496922

M. Pfaller and D. Diekema, Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem, Clinical Microbiology Reviews, vol.20, issue.1, pp.133-163, 2007.
DOI : 10.1128/CMR.00029-06

M. Arendrup, S. Sulim, A. Holm, L. Nielsen, S. Nielsen et al., Diagnostic Issues, Clinical Characteristics, and Outcomes for Patients with Fungemia, Journal of Clinical Microbiology, vol.49, issue.9, pp.3300-3308, 2011.
DOI : 10.1128/JCM.00179-11

A. Cleveland, M. Farley, L. Harrison, B. Stein, R. Hollick et al., Changes in Incidence and Antifungal Drug Resistance in Candidemia: Results From Population-Based Laboratory Surveillance in Atlanta and Baltimore, 2008-2011, Clinical Infectious Diseases, vol.55, issue.10, pp.1352-1361, 2008.
DOI : 10.1093/cid/cis697

M. Kollef, S. Micek, N. Hampton, J. Doherty, and A. Kumar, Septic Shock Attributed to Candida Infection: Importance of Empiric Therapy and Source Control, Clinical Infectious Diseases, vol.54, issue.12, pp.1739-1746, 2012.
DOI : 10.1093/cid/cis305

P. Pappas, C. Kauffman, D. Andes, D. Benjamin, . Jr et al., Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.48, issue.5, pp.503-535, 2009.
DOI : 10.1086/596757

O. Cornely, M. Bassetti, C. T. Garbino, J. Kullberg, B. Lortholary et al., ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients, Clinical Microbiology and Infection, vol.18, pp.19-37, 2012.
DOI : 10.1111/1469-0691.12039

J. Chow, Y. Golan, R. Ruthazer, A. Karchmer, Y. Carmeli et al., Risk factors for albicans and non-albicans candidemia in the intensive care unit*, Critical Care Medicine, vol.36, issue.7, pp.1993-1998, 2008.
DOI : 10.1097/CCM.0b013e31816fc4cd

N. Sipsas, R. Lewis, J. Tarrand, R. Hachem, K. Rolston et al., Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007), Cancer, vol.5, issue.20, pp.4745-4752, 2001.
DOI : 10.1002/cncr.24507

M. Bassetti, L. Taramasso, E. Nicco, M. Molinari, M. Mussap et al., Epidemiology, Species Distribution, Antifungal Susceptibility and Outcome of Nosocomial Candidemia in a Tertiary Care Hospital in Italy, PLoS ONE, vol.49, issue.9, p.24198, 2011.
DOI : 10.1371/journal.pone.0024198.t003

M. Arendrup, E. Dzajic, R. Jensen, H. Johansen, P. Kjaeldgaard et al., Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme, Clinical Microbiology and Infection, vol.19, issue.8, pp.343-353, 2013.
DOI : 10.1111/1469-0691.12212

O. Lortholary, M. Desnos-ollivier, K. Sitbon, A. Fontanet, S. Bretagne et al., Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients, Antimicrobial Agents and Chemotherapy, vol.55, issue.2, pp.532-538, 2011.
DOI : 10.1128/AAC.01128-10
URL : https://hal.archives-ouvertes.fr/hal-00818523

M. Bassetti, E. Righi, F. Ansaldi, M. Merelli, C. T. et al., A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality, Intensive Care Medicine, vol.51, issue.8, pp.839-845, 2014.
DOI : 10.1007/s00134-014-3310-z

A. Huang, D. Newton, A. Kunapuli, T. Gandhi, L. Washer et al., Impact of Rapid Organism Identification via Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Combined With Antimicrobial Stewardship Team Intervention in Adult Patients With Bacteremia and Candidemia, Clinical Infectious Diseases, vol.57, issue.9, pp.1237-1245, 2013.
DOI : 10.1093/cid/cit498

C. Leon, L. Ostrosky-zeichner, and M. Schuster, What???s new in the clinical and diagnostic management of invasive candidiasis in critically ill patients, Intensive Care Medicine, vol.36, issue.7, pp.808-819, 2014.
DOI : 10.1007/s00134-014-3281-0

L. Asmundsdottir, H. Erlendsdottir, and M. Gottfredsson, Nationwide Study of Candidemia, Antifungal Use, and Antifungal Drug Resistance in Iceland, 2000 to 2011, Journal of Clinical Microbiology, vol.51, issue.3, pp.841-848, 2000.
DOI : 10.1128/JCM.02566-12

S. Lockhart, N. Iqbal, A. Cleveland, M. Farley, L. Harrison et al., Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in Two U.S. Cities from 2008 to 2011, Journal of Clinical Microbiology, vol.50, issue.11, pp.3435-3442, 2008.
DOI : 10.1128/JCM.01283-12

M. Pfaller, D. Neofytos, D. Diekema, N. Azie, H. Meier-kriesche et al., Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance??) registry, 2004???2008, Diagnostic Microbiology and Infectious Disease, vol.74, issue.4, pp.323-331, 2004.
DOI : 10.1016/j.diagmicrobio.2012.10.003

B. Almirante, D. Rodriguez, B. Park, M. Cuenca-estrella, A. Planes et al., Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, 2002.

A. Colombo, M. Nucci, B. Park, S. Nouer, B. Arthington-skaggs et al., Epidemiology of Candidemia in Brazil: a Nationwide Sentinel Surveillance of Candidemia in Eleven Medical Centers, Journal of Clinical Microbiology, vol.44, issue.8, 2006.
DOI : 10.1128/JCM.00773-06

J. Chow, Y. Golan, R. Ruthazer, A. Karchmer, Y. Carmeli et al., in the Intensive Care Unit, Clinical Infectious Diseases, vol.46, issue.8, pp.1206-1213, 2008.
DOI : 10.1086/529435

M. Moretti, P. Trabasso, L. Lyra, R. Fagnani, M. Resende et al., bloodstream infection in a university reference hospital in southeast Brazil, Medical Mycology, vol.51, issue.3, pp.225-230, 2013.
DOI : 10.3109/13693786.2012.708107

D. Rodriguez, B. Almirante, M. Cuenca-estrella, J. Rodriguez-tudela, J. Mensa et al., Predictors of candidaemia caused by non-albicans Candida species: results of a population-based surveillance in Barcelona, Spain, Clinical Microbiology and Infection, vol.16, issue.11, pp.1676-1682, 2010.
DOI : 10.1111/j.1469-0691.2010.03208.x

E. Blanchard, O. Lortholary, K. Boukris-sitbon, M. Desnos-ollivier, F. Dromer et al., Prior Caspofungin Exposure in Patients with Hematological Malignancies Is a Risk Factor for Subsequent Fungemia Due to Decreased Susceptibility in Candida spp.: a Case-Control Study in Paris, France, Antimicrobial Agents and Chemotherapy, vol.55, issue.11, pp.5358-5361, 2011.
DOI : 10.1128/AAC.00690-11
URL : https://hal.archives-ouvertes.fr/hal-00818510

P. Fournier, C. Schwebel, D. Maubon, A. Vesin, B. Lebeau et al., Antifungal use influences Candida species distribution and susceptibility in the intensive care unit, Journal of Antimicrobial Chemotherapy, vol.66, issue.12, pp.2880-2886, 2011.
DOI : 10.1093/jac/dkr394
URL : https://hal.archives-ouvertes.fr/hal-00818509

E. Dannaoui, M. Desnos-ollivier, D. Garcia-hermoso, F. Grenouillet, S. Cassaing et al., Candida spp. with acquired echinocandin resistance, France, Emerg Infect Dis, vol.18, pp.2004-201086, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00759177

B. Alexander, M. Johnson, C. Pfeiffer, C. Jimenez-ortigosa, J. Catania et al., Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations, Clinical Infectious Diseases, vol.56, issue.12, pp.1724-1732, 2013.
DOI : 10.1093/cid/cit136

D. Horn, D. Neofytos, E. Anaissie, J. Fishman, W. Steinbach et al., Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry, Clinical Infectious Diseases, vol.48, issue.12, pp.1695-1703, 2009.
DOI : 10.1086/599039

P. Munoz, M. Giannella, C. Fanciulli, J. Guinea, M. Valerio et al., Candida tropicalis fungaemia: incidence, risk factors and mortality in a general hospital, Clinical Microbiology and Infection, vol.17, issue.10, pp.1538-1545, 2011.
DOI : 10.1111/j.1469-0691.2010.03338.x

M. Slavin, T. Sorrell, D. Marriott, K. Thursky, Q. Nguyen et al., Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death, Journal of Antimicrobial Chemotherapy, vol.65, issue.5, pp.1042-1051, 2010.
DOI : 10.1093/jac/dkq053

G. Kumar, N. Kumar, A. Taneja, T. Kaleekal, S. Tarima et al., Nationwide Trends of Severe Sepsis in the 21st Century (2000???2007), Chest, vol.140, issue.5, pp.1223-1231, 2000.
DOI : 10.1378/chest.11-0352

T. Williams, K. Ho, G. Dobb, J. Finn, M. Knuiman et al., Changes in case-mix and outcomes of critically ill patients in an Australian tertiary intensive care unit, Anaesth Intensive Care, vol.38, pp.703-709, 2010.

D. Gaieski, J. Edwards, M. Kallan, and B. Carr, Benchmarking the Incidence and Mortality of Severe Sepsis in the United States*, Critical Care Medicine, vol.41, issue.5, pp.1167-1174, 2013.
DOI : 10.1097/CCM.0b013e31827c09f8

E. Stevenson, A. Rubenstein, G. Radin, R. Wiener, and A. Walkey, Two Decades of Mortality Trends Among Patients With Severe Sepsis, Critical Care Medicine, vol.42, issue.3, pp.625-631, 2014.
DOI : 10.1097/CCM.0000000000000026

D. Andes, N. Safdar, J. Baddley, G. Playford, A. Reboli et al., Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials, Clinical Infectious Diseases, vol.54, issue.8, pp.1110-1122, 2012.
DOI : 10.1093/cid/cis021

K. Garey, M. Rege, M. Pai, D. Mingo, K. Suda et al., Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi???Institutional Study, Clinical Infectious Diseases, vol.43, issue.1, pp.25-31, 2006.
DOI : 10.1086/504810

M. Zilberberg, M. Kollef, H. Arnold, A. Labelle, S. Micek et al., Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study, BMC Infectious Diseases, vol.12, issue.1, p.150, 2010.
DOI : 10.1186/cc6212

A. Labelle, S. Micek, N. Roubinian, and M. Kollef, Treatment-related risk factors for hospital mortality in Candida bloodstream infections*, Critical Care Medicine, vol.36, issue.11, pp.2967-2972, 2008.
DOI : 10.1097/CCM.0b013e31818b3477

M. Pai, R. Turpin, and K. Garey, Association of Fluconazole Area under the Concentration-Time Curve/MIC and Dose/MIC Ratios with Mortality in Nonneutropenic Patients with Candidemia, Antimicrobial Agents and Chemotherapy, vol.51, issue.1, pp.35-39, 2007.
DOI : 10.1128/AAC.00474-06